company background image
9960 logo

Kindstar Globalgene Technology SEHK:9960 Stock Report

Last Price

HK$1.30

Market Cap

HK$1.3b

7D

-3.0%

1Y

-15.6%

Updated

15 Oct, 2024

Data

Company Financials +

Kindstar Globalgene Technology, Inc.

SEHK:9960 Stock Report

Market Cap: HK$1.3b

9960 Stock Overview

An investment holding company, provides clinical testing services in the People’s Republic of China.

9960 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Kindstar Globalgene Technology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kindstar Globalgene Technology
Historical stock prices
Current Share PriceHK$1.30
52 Week HighHK$1.79
52 Week LowHK$0.93
Beta0.69
11 Month Change23.81%
3 Month Change-5.80%
1 Year Change-15.58%
33 Year Change-75.70%
5 Year Changen/a
Change since IPO-85.62%

Recent News & Updates

Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 04
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings

Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story

Oct 03
Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story

Recent updates

Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 04
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings

Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story

Oct 03
Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story

We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings

Apr 03
We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings

Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Aug 22
Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts

Aug 18
Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts

We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate

Jul 07
We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate

Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 28
Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Shareholder Returns

9960HK HealthcareHK Market
7D-3.0%-7.1%-6.2%
1Y-15.6%-26.3%17.6%

Return vs Industry: 9960 exceeded the Hong Kong Healthcare industry which returned -26.3% over the past year.

Return vs Market: 9960 underperformed the Hong Kong Market which returned 17.6% over the past year.

Price Volatility

Is 9960's price volatile compared to industry and market?
9960 volatility
9960 Average Weekly Movement6.6%
Healthcare Industry Average Movement7.7%
Market Average Movement8.7%
10% most volatile stocks in HK Market18.5%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 9960 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 9960's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20033,193Shiang Huangwww.kindstar.com.cn/en/

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases.

Kindstar Globalgene Technology, Inc. Fundamentals Summary

How do Kindstar Globalgene Technology's earnings and revenue compare to its market cap?
9960 fundamental statistics
Market capHK$1.28b
Earnings (TTM)HK$10.04m
Revenue (TTM)HK$1.03b

122.0x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9960 income statement (TTM)
RevenueCN¥947.84m
Cost of RevenueCN¥513.76m
Gross ProfitCN¥434.08m
Other ExpensesCN¥424.88m
EarningsCN¥9.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0098
Gross Margin45.80%
Net Profit Margin0.97%
Debt/Equity Ratio10.8%

How did 9960 perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

268%

Payout Ratio